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Tyrosinase catalyzes the conversion of tyrosine to dihydroxyphenylalanine
quinone, which is the main precursor for the biosynthesis of melanin. The
enzyme from Agaricus bisporus, the common button mushroom, was purified
and crystallized in two different space groups. Crystals belonging to space group
P21 (unit-cell parameters a = 104.2, b = 105.0, c = 119.1 A˚,  = 110.6
, four
molecules per asymmetric unit) diffracted to 3.0 A˚ resolution. Crystals
belonging to space group P21212 (unit-cell parameters a = 104.0, b = 104.5,
c = 108.4 A˚, two molecules per asymmetric unit) diffracted to 2.6 A˚ resolution. It
was essential to include 5 mM HoCl3 in all crystallization conditions in order to
obtain well diffracting crystals.
1. Introduction
Tyrosinase (EC 1.14.18.1) is a copper-containing monooxygenase that
is widely distributed in nature, occurring in organisms from all phyla.
It catalyzes the o-hydroxylation of monophenols (monophenolase
activity) and the subsequent oxidation of the o-diphenols formed to
the corresponding o-quinones (diphenolase activity) (Van Gelder et
al., 1997), which are precursors for the biosynthesis of melanins. The
precise physiological function of the enzyme is not well understood.
In mammals, including humans, the enzyme is mainly found in
melanocytes, which are pigment-producing cells. The mammalian
enzyme has been implicated in pigmentary diseases such as albinism,
vitiligo and other melanin-related syndromes (Cesarini, 1996;
Hearing, 2005).
In the mushroom Agaricus bisporus, tyrosinase has been proposed
to be involved in defence mechanisms against pathogens because of
the bacteriostatic properties of o-quinones and melanins and because
of the inducibility of at least one tyrosinase isoform upon microbial
challenge (Soler-Rivas et al., 1999). The enzyme is also an important
factor in the browning of the mushroom upon aging and microbial
infection (Soler-Rivas et al., 1999) and consequently there is sub-
stantial interest in its catalytic properties (Espin, Varon et al., 2000;
Fenoll et al., 2002; Sa´nchez-Ferrer et al., 1995) and its inhibition
(Kubo et al., 2000; Ley & Bertram, 2001; Zhang et al., 2006).
To date, four genes coding for A. bisporus tyrosinase have been
described. These genes, Abppo1 (UniProt protein-sequence database
entry Q00024) and Abppo2 (O42713) (Wichers et al., 2003), and
Abppo3 (C7FF04) and Abppo4 (C7FF05) (Wu et al., 2010), code for
proteins with a molecular mass of 64–67 kDa. However, isolation of
the enzyme directly from mushroom fruit bodies yields a hetero-
tetramer composed of two subunits of 43–48 kDa (H chain) and two
subunits of 13–14 kDa (L chain) (H2L2 configuration; Strothkamp et
al., 1976). This information led to the hypothesis that tyrosinase is
initially formed as a monomeric 64 kDa latent precursor which can be
proteolytically activated, resulting in 43 kDa active forms (Espin,
Soler-Rivas et al., 2000). The nature of the L chain is not known.
Although the L chain may represent the C-terminal fragment
resulting from proteolytic cleavage of the latent precursor, it may also
be an unrelated protein that is copurified with active tyrosinase and
that is difficult to remove (Flurkey & Inlow, 2008).
X-ray absorption studies have indicated thatA. bisporus tyrosinase
contains two copper ions in its active site with spectroscopic prop-
erties resembling those of the two copper ions found in molluscan
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haemocyanin, a copper-containing oxygen-carrier protein (Della
Longa et al., 1996). The presence of two copper ions in tyrosinase has
also been shown in the crystal structure of Streptomyces castaneo-
globisporus tyrosinase (Matoba et al., 2006), with each of the two
copper ions being coordinated by three histidine side chains.
However, in A. bisporus tyrosinase the side chain of one of these
copper-coordinating histidine residues is covalently linked via a
thioether bond to the side chain of the preceding cysteine residue in
the C-X-H sequence motif (Van Gelder et al., 1997). The role of this
thioether bond remains elusive. Here, we report the purification and
crystallization of commercially available mushroom tyrosinase and
preliminary X-ray diffraction data analysis as an initial step towards
the elucidation of the three-dimensional structure of the enzyme.
2. Materials and methods
2.1. Sample preparation
Mushroom tyrosinase powder was purchased from Sigma (Sigma–
Aldrich, catalogue No. T3824-250KU) and was purified at 277 K
essentially as described previously (Schurink et al., 2007). The
mushroom tyrosinase powder was dissolved in 50 mM sodium phos-
phate buffer pH 6.5 to a concentration of 10 mg ml1. Insoluble
material was removed by centrifugation at 277 K and 12 000g for
15 min. The supernatant was carefully recovered and was loaded onto
a 10/30 Superdex S-200 column (Amersham Biosciences) equili-
brated with 100 mMHEPES buffer pH 7.5 containing 10 mM calcium
chloride. Elution from the gel-filtration column was carried out with
the same buffer at a constant flow rate of 0.25 ml min1. Fractions
with tyrosinase activity were pooled and concentrated with con-
comitant buffer exchange to 10 mM HEPES pH 7.5 over a 10 kDa
cutoff Amicon membrane (Millipore) to a final protein concentration
of approximately 6 mg ml1. The concentrated protein was either
directly subjected to crystallization experiments or frozen at 253 K
for storage.
2.2. Determination of protein concentration and enzyme activity
The protein concentration was estimated from the absorption
at 280 nm using the experimentally determined " value of
132 000M1 cm1. Absorbance measurements were performed with
a Nanodrop ND-1000 spectrometer (Nanodrop Technologies Inc.,
Wilmington, USA).
Enzyme activity was measured at 298 K by a colorimetric method
essentially as described previously (Espin et al., 1997) using
3,4-dihydroxyphenylalanine (l-DOPA) as substrate. One unit of
tyrosinase activity is defined as the formation of 1 mmol l-DOPA
quinone per minute. Briefly, in a 1 ml cuvette, 100 ml of a 5 mM
3-methyl-2-benzothiazolinone hydrazone (MBTH) solution in water
was mixed with 800 ml l-DOPA solution (18 mM in 50 mM sodium
phosphate buffer pH 6.5). The reaction was started by the addition of
100 ml enzyme solution to the reaction mixture. The increase in the
absorbance at 484 nm was followed during the first 3 min. The
measurements were carried out in an Ultrospec 4300 Pro spectro-
meter equipped with a temperature-control unit (Amersham Bio-
sciences) interfaced online to a computer. The spectra were recorded
and processed with the time-drive measurement module (SWIFT II
program, v.2.01, Amersham Biosciences).
2.3. Characterization of protein samples
The purity of the enzyme was routinely checked by SDS–PAGE
using a PhastGel System (Amersham Biosciences) with pre-cast SDS
gels and electrode strips. Staining was conducted in the same system
using silver nitrate as the staining solution.
The temperature-stability of the protein in solution was analyzed
by thermal shift assay (Ericsson et al., 2006). Briefly, 5 ml 200-fold
diluted SYPRO Orange solution (Invitrogen, Breda, The Nether-
lands) as a molecular probe, 5 ml 4.5 mg ml1 enzyme solution in
water, 2.5 ml 1M buffer stock solution and 2.5–5 ml additive stock
solution were mixed in a 96-well thin-wall PCR plate (Bio-Rad). The
final reaction volume was adjusted to 25 ml by adding an appropriate
volume of filtered and degassed Milli-Q water. The plate was sealed
with optical quality sealing tape (Bio-Rad Laboratories BV,
Veenendaal, The Netherlands). The sealed plate was inserted into
a real-time PCR machine (iCycler, Bio-Rad Laboratories BV,
Veenendaal, The Netherlands) and was heated from 293 to 363 K
with a 0.5 K increment per 20 s. The changes in fluorescence of the
SYPRO Orange probe were monitored with a fluorescence detector
(MyIQ single-colour RT-PCR detection system, Bio-Rad) at excita-
tion and emission wavelengths of 490 and 575 nm, respectively.
The monodispersity of the enzyme was analyzed by dynamic light
scattering using a DynaPro dynamic light-scattering instrument
(Wyatt Technologies, Santa Barbara, USA). The protein sample
(1 mg ml1) was centrifuged at 12 000g for 15 min at 277 K and the
supernatant was carefully transferred into a DLS cuvette. Measure-
ments were performed at both 298 and 277 K.
2.4. Crystallization procedures
Initial screening for crystallization conditions was carried out at
298 K by the sitting-drop vapour-diffusion method employing an
Oryx-6 crystallization robot (Douglas Instruments, Hungerford,
England) equipped with an anti-evaporation shielding plate. The
following commercial screens were used in 96-well CrystalClear strips
for sitting-drop setups (Hampton Research): Structure Screens I and
II (Molecular Dimensions, Apopka, USA), Cryoscreens I and II
(Emerald BioSystems, Bainbridge Island, USA) and the JCSG+ Suite
(Qiagen, Venlo, The Netherlands). The starting volume of the drop
was 0.3 ml, consisting of 0.12 ml protein solution and 0.18 ml reservoir
solution. Optimization of promising crystallization conditions was
performed with the hanging-drop vapour-diffusion method, varying
the precipitant type and concentration, the temperature and the pH
and using additives.
2.5. Data collection and processing
Prior to X-ray diffraction analysis, crystals were transferred into a
cryoprotectant solution consisting of 15% PEG 4000, 20% PEG 400,
1 mM HoCl3 and 100 mM sodium acetate buffer pH 4.6 before flash-
freezing them in liquid nitrogen. X-ray diffraction experiments were
carried out on beamlines BM16, ID23-2 and ID14-4 at the ESRF
(Grenoble, France). Diffraction data were recorded at 100 K with the
CCD detector available at the beamline with 0.5–1.0 oscillations. The
data sets were processed using either XDS (Kabsch, 2010) or
MOSFLM (Leslie, 2006). Scaling and merging were performed with
SCALA (Evans, 2006), which is part of the CCP4 program suite
(Collaborative Computational Project, Number 4, 1994).
3. Results and discussion
Commercially available mushroom tyrosinase was successfully puri-
fied using a single gel-filtration step. In the elution profile, tyrosinase
activity was detected in a peak with a retention time corresponding to
a molecular mass of 120 kDa, as expected for the mass of the H2L2
form of mushroom tyrosinase (Strothkamp et al., 1976). Furthermore,
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SDS–PAGE analysis of this peak confirmed the presence of the heavy
(H) and light (L) chains, with molecular weights of 45 and 14 kDa,
respectively, which is in agreement with previous reports (Schurink et
al., 2007). Analysis of the protein content and specific activity indi-
cated that approximately 50% of the total protein in the mushroom
tyrosinase powder consisted of tyrosinase. The purification scheme
recovered up to 90% of the enzyme activity.
The thermostability of tyrosinase was investigated by following the
unfolding of the protein as a function of temperature under various
conditions (Ericsson et al., 2006). A shift in the melting temperature
(Tm) of the protein to higher values indicates an increase in
thermostability. Fig. 1(a) shows that the enzyme demonstrated the
highest Tm value in 100 mM HEPES buffer pH 7.5, 10 mM CaCl2. In
the absence of calcium or when the calcium was replaced by sodium
the Tm value shifted to lower temperatures. Based on this observa-
tion, 100 mM HEPES buffer pH 7.5 with 10 mM CaCl2 was chosen
for the purification.
To assess the aggregation behaviour of tyrosinase, a dynamic light-
scattering experiment was performed. Without applying any noise
reduction or peak filtering, the fit on mass showed one main peak
with a mean Rh of 4.4 nm and 6% polydispersity, indicating a
monodisperse solution at 298 K (Fig. 1b). The calculated mass of this
peak was 110 kDa, which is in agreement with the results of size-
exclusion chromatography, and confirmed the presence of an H2L2
tetramer in solution (Strothkamp et al., 1976). Although some noise
was observed owing to protein aggregation, it resulted from less than
0.1% of the mass in the sample. Because the monodispersity of the
enzyme solution was reduced at 277 K (data not shown), subsequent
crystallization experiments were carried out at 298 K.
Initial crystals were obtained with the JCSG+ screen after 48 h
at 298 K using a reservoir solution composed of 8% PEG 4000 in
100 mM sodium acetate buffer pH 4.6. However, these crystals only
diffracted to 8 A˚ resolution (BM16, ESRF, Grenoble). Optimiza-
tion using the hanging-drop vapour-diffusion method, followed by an
extensive additive screen, revealed that 5 mM HoCl3 improved the
diffraction quality of the crystals. After this discovery, plate-shaped
crystals suitable for X-ray data collection (Fig. 2) were routinely
obtained from drops consisting of 2 ml protein solution (6 mg ml1)
and 2 ml reservoir solution, which were suspended over 800 ml
reservoir solution consisting of 10%(w/v) PEG 4000, 100 mM sodium
acetate buffer pH 4.6 and 5 mM HoCl3. Crystals with reasonable size
(200  200  50 mm) could be obtained within 4–5 d. They diffracted
to 2.6 A˚ resolution using synchrotron radiation (ESRF, Grenoble).
Finally, it appeared to be necessary to include 1 mM HoCl3 in the
cryoprotectant solution for reproducible diffraction by the crystals.
The crystals obtained were analyzed by X-ray diffraction (Table 1).
They belonged to either space group P21 or space group P21212.
Crystals with space group P21 had unit-cell parameters a = 104.2,
b = 105.0, c = 119.1 A˚,  = 110.6 and diffracted to 3.0 A˚ resolution.
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Figure 1
Stability and monodispersity of tyrosinase in solution. (a) Thermal unfolding of
tyrosinase in 100 mM HEPES buffer pH 7.5 (black line), in 100 mM HEPES buffer
with an additional 10 mM calcium chloride (circles) or in 100 mM HEPES buffer
with an additional 10 mM sodium chloride (crosses). (b) Monodispersity of
tyrosinase in 100 mM HEPES buffer pH 7.5 containing 10 mM CaCl2 at 298 K.
Figure 2
Plate-shaped crystals of mushroom tyrosinase.
Table 1
Summary of crystallographic data collection and processing.
Values in parentheses are for the highest resolution shell.
Native P21 Native P21212
Beamline ESRF ID23-2 ESRF ID14-4
Wavelength (A˚) 0.8726 0.9395
Resolution (A˚) 50.0–3.00 54.2–2.60
Unit-cell parameters (A˚, ) a = 104.2, b = 105.0,
c = 119.1,  = 110.6
a = 104.0, b = 104.5,
c = 108.4,  = 90
Rmerge† 0.16 (0.34) 0.12 (0.45)
Rp.i.m.† 0.11 (0.24) 0.07 (0.28)
Mean I/(I) 7.3 (2.3) 8.2 (2.3)
Completeness (%) 88.9 (90.5) 94.8 (81.8)
Multiplicity 2.8 (2.9) 4.0 (2.7)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ; Rp.i.m. =
P
hkl ½1=ðN  1Þ1=2P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the integrated intensity of a
reflection, hI(hkl)i is the mean intensity of multiple corresponding symmetry-related
reflections and N is the multiplicity of the given reflections.
Crystals with space group P21212 had unit-cell parameters a = 104.0,
b = 104.5, c = 108.4 A˚ and diffracted to 2.6 A˚ resolution. Assuming
the presence of four 60 kDa HL heterodimers per asymmetric unit in
the P21 crystals and two HL heterodimers per asymmetric unit in
the P21212 crystals gave similar values for the Matthews coefficient
and solvent content of 2.4 A˚3 Da1 and 49%, respectively. Data-
collection statistics are summarized in Table 1.
An SDS–PAGE analysis of a tyrosinase crystal showed the
presence of both the 45 and 14 kDa polypeptides, indicating that both
the H and L chains are present in the crystal. Furthermore, an X-ray
fluorescence scan of a tyrosinase crystal grown in the absence of
HoCl3 showed the presence of copper in the protein crystal (Fig. 3).
Finally, significant tyrosinase activity was observed after dissolving
a crystal that had been exposed to X-rays. Since the activity of the
enzyme relies on the presence of the copper in the active site, this
result not only confirmed the presence of copper but also indicates
that the copper is still functional. Thus, we have crystallized active
mushroom tyrosinase. We are currently trying to solve the structure
of the enzyme by molecular replacement with multiple-crystal aver-
aging using as search models the structures of the core domain of
Octopus dofleini haemocyanin (PDB entry 1js8; Cuff et al., 1998) and
S. castaneoglobisporus tyrosinase (PDB entry 1wx2; Matoba et al.,
2006), which have sequence identities of 19% and 20% for 274 and
275 aligned amino acids, respectively.
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Figure 3
Energy scan of a tyrosinase crystal. The peak occurs at an energy of 8.995 
0.001 keV, which is specific for copper in tyrosinase (Della Longa et al., 1996).
